PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-24 (1)

Date Title Company
24-Feb-2026 QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS Businesswire